- Application under evaluation
- CVMP opinion
- European Commission decision
Overview
The market authorisation for Zubrin has been withdrawn at the request of the marketing-authorisation holder.
Zubrin : EPAR - Summary for the public
English (EN) (510.23 KB - PDF)
español (ES) (511.13 KB - PDF)
čeština (CS) (595.78 KB - PDF)
dansk (DA) (510.17 KB - PDF)
Deutsch (DE) (513.33 KB - PDF)
eesti keel (ET) (510.33 KB - PDF)
ελληνικά (EL) (664.57 KB - PDF)
français (FR) (513.24 KB - PDF)
italiano (IT) (511.22 KB - PDF)
latviešu valoda (LV) (581.56 KB - PDF)
lietuvių kalba (LT) (536.1 KB - PDF)
magyar (HU) (589.67 KB - PDF)
Nederlands (NL) (510.07 KB - PDF)
polski (PL) (597.7 KB - PDF)
português (PT) (511.85 KB - PDF)
slovenčina (SK) (569.98 KB - PDF)
slovenščina (SL) (589.46 KB - PDF)
Suomi (FI) (510 KB - PDF)
svenska (SV) (509.65 KB - PDF)
Product information
Zubrin : EPAR - Product Information
English (EN) (361.74 KB - PDF)
български (BG) (1.39 MB - PDF)
español (ES) (354.35 KB - PDF)
čeština (CS) (876.13 KB - PDF)
dansk (DA) (361.88 KB - PDF)
Deutsch (DE) (380.8 KB - PDF)
eesti keel (ET) (353.43 KB - PDF)
ελληνικά (EL) (1.1 MB - PDF)
français (FR) (363.75 KB - PDF)
íslenska (IS) (608.9 KB - PDF)
italiano (IT) (369.61 KB - PDF)
latviešu valoda (LV) (919.36 KB - PDF)
lietuvių kalba (LT) (1.36 MB - PDF)
magyar (HU) (1.04 MB - PDF)
Malti (MT) (898.07 KB - PDF)
Nederlands (NL) (369.61 KB - PDF)
norsk (NO) (663.7 KB - PDF)
polski (PL) (696.28 KB - PDF)
português (PT) (370.61 KB - PDF)
română (RO) (907.36 KB - PDF)
slovenčina (SK) (1.1 MB - PDF)
slovenščina (SL) (738.16 KB - PDF)
Suomi (FI) (347.73 KB - PDF)
svenska (SV) (339.08 KB - PDF)
Zubrin : EPAR - All Authorised presentations
English (EN) (243.39 KB - PDF)
español (ES) (243.72 KB - PDF)
čeština (CS) (768.39 KB - PDF)
dansk (DA) (243.34 KB - PDF)
Deutsch (DE) (460.26 KB - PDF)
eesti keel (ET) (15.67 KB - PDF)
ελληνικά (EL) (320.74 KB - PDF)
français (FR) (243.6 KB - PDF)
italiano (IT) (243.26 KB - PDF)
latviešu valoda (LV) (321.63 KB - PDF)
lietuvių kalba (LT) (304.46 KB - PDF)
magyar (HU) (308.89 KB - PDF)
Malti (MT) (322.75 KB - PDF)
Nederlands (NL) (243.75 KB - PDF)
polski (PL) (280.86 KB - PDF)
português (PT) (243.78 KB - PDF)
slovenčina (SK) (281.56 KB - PDF)
slovenščina (SL) (278.91 KB - PDF)
Suomi (FI) (240.48 KB - PDF)
svenska (SV) (244 KB - PDF)
Product details
- Name of medicine
- Zubrin
- Active substance
- tepoxalin
- International non-proprietary name (INN) or common name
- tepoxalin
- Species
- Dogs
- Anatomical therapeutic chemical veterinary (ATCvet) code
- QM01AE92
Pharmacotherapeutic group
Musculo-skeletal systemTherapeutic indication
Reduction of inflammation and relief of pain caused by acute and chronic musculoskeletal disorders.
Authorisation details
- EMA product number
- EMEA/V/C/000057
- Marketing authorisation holder
- Intervet International B. V.
Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands - Marketing authorisation issued
- 13/03/2001
- Revision
- 13
Assessment history
Zubrin : EPAR - Procedural steps taken and scientific information after authorisation
English (EN) (329.28 KB - PDF)